On the other hand, it is believed that the stimulation of S1P3, which is ubiquitously expressed throughout the body, may be associated with some adverse reactions from fingolimod medication, such as headache, hypertension, stroke [23], cough, dyspnea, and macular edema [24]. Here, S1PR3 is linked to stroke disorder.